Let's get back to following job opportunities at $QURE instead of this insane price reaction to today's great news LOL. 1 new job added today bringing total open jobs to 26. Clearly planning for commercial rollout.
Today's price will look like the gift it is within days/weeks.
I believe the thing today's sellers in $QURE are missing is the connection between these 2 filings and what @uniQure_NV management knows about the 4-year and longer data on AMT130 trial. There are patients on the trial in the hi dose group who were literally treated 5 years ago.
Great post on $QURE prices and market caps. I would like to add that we now have cash of >$765 million ($10+/share), insignificant debt of only $50 million, potential to receive milestones from @CSL from what turned out to be an unbelievably great Hemgenix deal, platform with TLE
Best management team in bio is @uniQure_NV$QURE. Today's news was further confirmation that they almost always hit or exceed their guidance.
Funny thing is how nothing ever leaks either. Yesterday was one of the lowest volume days in months and down before the news.
OK it looks like $QURE is done updating job listing page (at least for today) and currently lists 25 jobs as shown below. Yesterday there were some minor issues I noticed with a few jobs.
Today there are 7 jobs that were listed yesterday that don't appear today. Were they
I just read another analyst report for $QURE and each time I read one, I can't help but laugh at how comical their PEAK revenue estimates are for AMT130. From what I have read, most are between $2.5-4.0 billion. That implies treating only 2,000 patients annually at PEAK REVENUE.
Let's see how accurate $QURE investors are with their predictions next month. I believe the 24.9% of participants will be proven right. Today is a small taste of what's to come.
https://t.co/Vu83VONzc4
